NASDAQ
WOK
Last Price
US $2.09
KEY FIGURES
MKT CAP
$5.1M
EPS
TTM
$-10.35
EPS Growth (1Y)
37.07%
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
0.02x
YIELD
-
GROWTH (5Y CAGR)
Revenue
Valuation
Financial
Performance
Cash flow to debt coverage
WORK Medical Technology Group Ltd. Class A cash flow to debt ratio of 96.84% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Free cash flow growth
WORK Medical Technology Group Ltd. Class A's free cash flow has increased -142.76% from $-11.49M last year to $4.91M, signaling increasing performance
Debt-to-equity ratio
WORK Medical Technology Group Ltd. Class A's debt to equity ratio is 0.35, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
WORK Medical Technology Group Ltd. Class A's debt has decreased relative to shareholder equity from 1.02 last year to 0.35 today, signaling strengthened financials
Net debt to EBITDA
WORK Medical Technology Group Ltd. Class A has a net debt to EBITDA ratio of 6.95x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Interest coverage
WORK Medical Technology Group Ltd. Class A's interest coverage ratio is -4.96, which means that the company struggles to meet interest obligations, signaling financial risk.
Profit margin growth
WORK Medical Technology Group Ltd. Class A's profit margin has increased (-64.12%) in the last year from -30.35% to -10.89%, signaling increasing performance
Current ratio
WORK Medical Technology Group Ltd. Class A's short-term assets of $20.46M exceed its short-term liabilities of $11.97M
Return on assets
WORK Medical Technology Group Ltd. Class A's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
WORK Medical Technology Group Ltd. Class A's return on equity of -6.86%, is lower than 15.00%, indicating bad performance
Earnings quality
WORK Medical Technology Group Ltd. Class A's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
WORK Medical Technology Group Ltd. Class A has insufficient public price history to evaluate earnings stability.
Positive free cash flow
WORK Medical Technology Group Ltd. Class A has positive free cash flow, indicating the company generates cash after capital expenditures
Free cash flow yield
WORK Medical Technology Group Ltd. Class A has a free cash flow yield of 97.18%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Earnings growth
WORK Medical Technology Group Ltd. Class A's yearly earnings has increased -69.28% since last year from $-3.49M to $-1.07M, signaling increasing performance
Revenue growth
WORK Medical Technology Group Ltd. Class A's yearly revenue has decreased 14.41% since last year from $11.51M to $9.85M, signaling decreasing performance
Return on invested capital
ROIC -9.04% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
WORK Medical Technology Group Ltd. Class A's 3-year revenue CAGR of -20.65% is negative, indicating declining revenue over the past 3 years
Revenue consistency
WORK Medical Technology Group Ltd. Class A has insufficient public price history to evaluate revenue consistency.
Return on equity consistency
WORK Medical Technology Group Ltd. Class A has insufficient public price history to evaluate ROE consistency.
Cash Flow Valuation (DCF)
WORK Medical Technology Group Ltd. Class A has insufficient data to evaluate this check.
Earnings yield (TTM)
WORK Medical Technology Group Ltd. Class A has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
WORK Medical Technology Group Ltd. Class A is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
WORK Medical Technology Group Ltd. Class A has an EV/EBITDA ratio of 21.85x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
PEG ratio (TTM/FY)
WORK Medical Technology Group Ltd. Class A has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
WORK Medical Technology Group Ltd. Class A has a price-to-book ratio of 0.01x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
WORK Medical Technology Group Ltd. Class A has a price-to-sales ratio of 0.02x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-6.86%
Return on equity
ROIC: -9.04%
Valuation History
-
Price to Earnings
EV/EBITDA: -5.3X
Cash flow
Profit margin
-
EBITDA
-
Cash flow
-
Cash Flow (DCF)
Fair Value
Market $2.09
—
Default assumptions
EBITDA Multiple
Fair Value
Market $2.09
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.